You are viewing AANS Neurosurgeon Volume 27, Number 3, 2018. View our current issue, Volume 28, Number 4, 2019

AANS Neurosurgeon | Volume 27, Number 3, 2018

Advertisement

Longtime Antidepressant Could Slow Parkinson's

Print Friendly, PDF & Email

Michigan State University scientists now have early proof that an antidepressant drug that’s been around for more than 50 years could slow the progression of Parkinson’s.

In a proof-of-concept study, the drug nortriptyline, which has been used to treat depression and nerve pain, stopped the growth of abnormal proteins that can build up in the brain and lead to the development of the disease.

“Depression is a very frequent condition associated with Parkinson’s, so we became interested in whether an antidepressant could modify how the disease progresses,” said Tim Collier, lead author of the federally funded study and a neuroscientist at MSU.

Click here to read more.

Calendar/Courses

Bypass 2020 – Anniversary Symposium
Jan. 8-10, 2020; Switzerland Frauenklinikstrass, Switzerland

Sun Valley Stroke Conference 2020
Jan. 9-12, 2020; Sun Valley, Idaho

Kranzler Chicago Review Course in Neurosurgery
Jan. 24-31, 2020; Chicago

Comments are closed.